SUBSCRIBERS
Drug industry faces era of moderate price increases, says Valeant CEO
Published Fri, Oct 23, 2015 · 09:50 PM
New York
VALEANT Pharmaceuticals International, which has been criticised for raising drug prices and is being investigated by the US government, predicted this week that lower price increases are ahead for the whole industry.
Valeant chief executive J Michael Pearson told investors on Monday that the company's 2016 outlook is based on expectations for a new pricing environment wher…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Japan’s 7-Eleven convenience chain targets aggressive global growth
Bubble tea maker Chabaidao slumps 10% in Hong Kong’s biggest 2024 debut
Parental fury after stem cell bank ruins thousands of samples in Singapore
China’s bubble tea boom creates a half-dozen billionaires
US sues to block Coach owner’s US$8.5 billion buyout of Versace parent
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO